(Q43265869)

English

The dopamine D(2) receptor partial agonist aplindore improves motor deficits in MPTP-treated common marmosets alone and combined with L-dopa

scientific article published on 7 October 2009

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

17 November 2017

The dopamine D(2) receptor partial agonist aplindore improves motor deficits in MPTP-treated common marmosets alone and combined with L-dopa (English)

1 reference

Europe PubMed Central

PubMed publication ID

17 November 2017

author name string

Michael John Jackson

1

1 reference

Europe PubMed Central

PubMed publication ID

17 November 2017

Terrance H Andree

2

1 reference

Europe PubMed Central

PubMed publication ID

17 November 2017

Matthew Hansard

3

1 reference

Europe PubMed Central

PubMed publication ID

17 November 2017

Diane C Hoffman

4

1 reference

Europe PubMed Central

PubMed publication ID

17 November 2017

Mark R Hurtt

5

1 reference

Europe PubMed Central

PubMed publication ID

17 November 2017

John H Kehne

6

1 reference

Europe PubMed Central

PubMed publication ID

17 November 2017

Thomas A Pitler

7

1 reference

Europe PubMed Central

PubMed publication ID

17 November 2017

Lance A Smith

8

1 reference

Europe PubMed Central

PubMed publication ID

17 November 2017

Gary Stack

9

1 reference

Europe PubMed Central

PubMed publication ID

17 November 2017

Peter Jenner

10

1 reference

Europe PubMed Central

PubMed publication ID

17 November 2017

publication date

7 October 2009

1 reference

Europe PubMed Central

PubMed publication ID

17 November 2017

Journal of Neural Transmission

1 reference

Europe PubMed Central

PubMed publication ID

17 November 2017

117

1 reference

Europe PubMed Central

PubMed publication ID

17 November 2017

1

1 reference

Europe PubMed Central

PubMed publication ID

17 November 2017

55-67

1 reference

Europe PubMed Central

PubMed publication ID

17 November 2017

Partial dopamine agonist therapy of levodopa-induced dyskinesias

1 reference

https://api.crossref.org/works/10.1007%2FS00702-009-0323-9

21 January 2018

Advanced Parkinson's disease: use of partial dopamine agonist, ciladopa

1 reference

https://api.crossref.org/works/10.1007%2FS00702-009-0323-9

21 January 2018

A modification of receptor theory

1 reference

https://api.crossref.org/works/10.1007%2FS00702-009-0323-9

21 January 2018

Terguride in fluctuating parkinsonian patients: a double-blind study versus placebo

1 reference

https://pubmed.ncbi.nlm.nih.gov/19809864

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Antagonist effect of terguride in Parkinson's disease

1 reference

https://pubmed.ncbi.nlm.nih.gov/19809864

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

L-dopa dose and the duration and severity of dyskinesia in primed MPTP-treated primates

1 reference

https://pubmed.ncbi.nlm.nih.gov/19809864

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Drug efficacy at G protein-coupled receptors

1 reference

https://pubmed.ncbi.nlm.nih.gov/19809864

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Decreased expression of l-dopa-induced dyskinesia by switching to ropinirole in MPTP-treated common marmosets

1 reference

https://pubmed.ncbi.nlm.nih.gov/19809864

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

D2 receptor partial agonists: treatment of CNS disorders of dopamine function

1 reference

https://pubmed.ncbi.nlm.nih.gov/19809864

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Dopamine receptor agonists: intrinsic activity vs. state of receptor

1 reference

https://pubmed.ncbi.nlm.nih.gov/19809864

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Preventing and controlling dyskinesia in Parkinson's disease--a view of current knowledge and future opportunities

1 reference

https://pubmed.ncbi.nlm.nih.gov/19809864

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Aplindore (DAB-452), a high affinity selective dopamine D2 receptor partial agonist

1 reference

https://pubmed.ncbi.nlm.nih.gov/19809864

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Treatment of Parkinson's disease with the partial dopamine agonist EMD 49980.

1 reference

https://pubmed.ncbi.nlm.nih.gov/19809864

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Levodopa motor complications in Parkinson's disease

1 reference

https://pubmed.ncbi.nlm.nih.gov/19809864

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Terguride in stable Parkinson's disease

1 reference

https://pubmed.ncbi.nlm.nih.gov/19809864

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Molecular mechanisms of L-DOPA-induced dyskinesia

1 reference

https://pubmed.ncbi.nlm.nih.gov/19809864

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effect of pulsatile administration of levodopa on dyskinesia induction in drug‐naïve MPTP‐treated common marmosets: Effect of dose, frequency of administration, and brain exposure

1 reference

https://pubmed.ncbi.nlm.nih.gov/19809864

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Limitations of current Parkinson's disease therapy

1 reference

https://pubmed.ncbi.nlm.nih.gov/19809864

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Pramipexole vs levodopa as initial treatment for Parkinson disease: a 4-year randomized controlled trial

1 reference

https://pubmed.ncbi.nlm.nih.gov/19809864

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Chronic L-DOPA administration induces dyskinesias in the 1-methyl-4- phenyl-1,2,3,6-tetrahydropyridine-treated common marmoset (Callithrix Jacchus).

1 reference

https://pubmed.ncbi.nlm.nih.gov/19809864

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

In vitro characterization of SLV308 (7-[4-methyl-1-piperazinyl]-2(3H)-benzoxazolone, monohydrochloride): a novel partial dopamine D2 and D3 receptor agonist and serotonin 5-HT1A receptor agonist

1 reference

https://pubmed.ncbi.nlm.nih.gov/19809864

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The partial dopamine receptor agonist terguride in the MPTP-induced hemiparkinsonian monkey model

1 reference

https://pubmed.ncbi.nlm.nih.gov/19809864

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effects of terguride, a partial D2 agonist, on MPTP-lesioned parkinsonian cynomolgus monkeys

1 reference

https://pubmed.ncbi.nlm.nih.gov/19809864

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A five-year study of the incidence of dyskinesia in patients with early Parkinson's disease who were treated with ropinirole or levodopa

1 reference

https://pubmed.ncbi.nlm.nih.gov/19809864

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Terguride stimulates locomotor activity at 2 months but not 10 months after 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine treatment of common marmosets

1 reference

https://pubmed.ncbi.nlm.nih.gov/19809864

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Combination treatment of the partial D2 agonist terguride with the D1 agonist SKF 82958 in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-lesioned parkinsonian cynomolgus monkeys

1 reference

https://pubmed.ncbi.nlm.nih.gov/19809864

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Frequency of levodopa-related dyskinesias and motor fluctuations as estimated from the cumulative literature

1 reference

https://pubmed.ncbi.nlm.nih.gov/19809864

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1007/S00702-009-0323-9

1 reference

Europe PubMed Central

PubMed publication ID

17 November 2017

Dimensions Publication ID

0 references

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

17 November 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q43265869&oldid=2205919679"